Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
KeyCorp sees FY21 NII up low single digits vs. prior 'relatively stable' outlook » 07:38
04/20/21
04/20
07:38
04/20/21
07:38
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Sees FY21 noninterest…

Sees FY21 noninterest income up mid-single digits vs. prior low single digits outlook, with noninterest expense relatively stable vs. prior down low single digits outlook. Now sees FY21 net charge-offs to average loans 35-45bps vs. prior 50-60bps view. The GAAP tax rate is still expected to be about 19%. Sees loans relatively stable, with deposits up mid-single digits for FY21.

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Hot Stocks
KeyCorp sees long-term ROTCE 16%-19%, cash efficiency ratio 54%-56% » 07:37
04/20/21
04/20
07:37
04/20/21
07:37
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Sees positive operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Earnings
KeyCorp reports Q1 EPS 61c, consensus 48c » 06:42
04/20/21
04/20
06:42
04/20/21
06:42
KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

Reports Q1 revenue…

Reports Q1 revenue $1.75B, consensus $1.69B. Reports Q1 book value per share $16.22. Reports Q1 CET1 capital ratio 9.8%. "This was a strong start to the year for Key as we executed our strategy, grew and expanded client relationships, and delivered positive operating leverage. Our results reflect strong credit quality as well as record first quarter revenues, with strength in our investment banking business and ongoing momentum from our consumer growth engines. We have continued to make investments in our business to position the company for success. In March, we successfully launched Laurel Road for Doctors, a digital platform tailored to the unique financial needs of healthcare professionals. Additionally, this platform expands our digital reach nationally, for this targeted client segment. Laurel Road for Doctors underscores our commitment to both targeted scale and digital transformation. Credit quality continued to be a strength this quarter. Our strong risk management practices contributed to broad-based improvement in our credit metrics," Chris Gorman, chairman and CEO said.

ShowHide Related Items >><<
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

Earnings
Synovus reports Q1 adjusted EPS $1.21, consensus 92c » 06:33
04/20/21
04/20
06:33
04/20/21
06:33
SNV

Synovus

$46.55 /

-0.53 (-1.13%)

Reports Q1 FTE revenue…

Reports Q1 FTE revenue $485.6M, consensus $486.31M. Reports Q1 net interest margin of 3.04% vs 3.12% sequentially.

ShowHide Related Items >><<
SNV Synovus
$46.55 /

-0.53 (-1.13%)

SNV Synovus
$46.55 /

-0.53 (-1.13%)

03/24/21 Seaport Global
Synovus initiated with a Buy at Seaport Global
03/24/21 Seaport Global
Synovus initiated with a Buy at Seaport Global
03/18/21 Morgan Stanley
Synovus price target raised to $56 from $52 at Morgan Stanley
03/08/21 Truist
Synovus price target raised to $52 from $45 at Truist
SNV Synovus
$46.55 /

-0.53 (-1.13%)

SNV Synovus
$46.55 /

-0.53 (-1.13%)

Yesterday
Earnings
Notable companies reporting before tomorrow's open » 20:25
04/19/21
04/19
20:25
04/19/21
20:25
JNJ

Johnson & Johnson

$162.98 /

+0.83 (+0.51%)

, PG

Procter & Gamble

$136.45 /

-0.72 (-0.52%)

, ABT

Abbott

$124.67 /

+0.3 (+0.24%)

, PM

Philip Morris

$91.63 /

-1.29 (-1.39%)

, LMT

Lockheed Martin

$391.87 /

+0.03 (+0.01%)

, TRV

Travelers

$154.45 /

-1.5 (-0.96%)

, FITB

Fifth Third

$37.91 /

-0.29 (-0.76%)

, KEY

KeyCorp

$20.43 /

-0.24 (-1.16%)

, OMC

Omnicom

$79.44 /

-0.22 (-0.28%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $2.34... Procter & Gamble (PG), consensus $1.19... Abbott (ABT), consensus $1.27... Philip Morris (PM), consensus $1.40... Lockheed Martin (LMT), consensus $6.30... Travelers (TRV), consensus $2.37... Fifth Third Bancorp (FITB), consensus 69c... KeyCorp (KEY), consensus 48c... Omnicom (OMC), consensus $1.13.

ShowHide Related Items >><<
TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
ABT Abbott
$124.67 /

+0.3 (+0.24%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
PM Philip Morris
$91.63 /

-1.29 (-1.39%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
TRV Travelers
$154.45 /

-1.5 (-0.96%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

04/09/21 Jefferies
Fifth Third price target raised to $44 from $36 at Jefferies
04/07/21 Barclays
Fifth Third price target raised to $43 from $37 at Barclays
04/01/21 Wells Fargo
Fifth Third price target raised to $36 from $28 at Wells Fargo
04/01/21 Deutsche Bank
Fifth Third price target raised to $38 from $30 at Deutsche Bank
KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
OMC Omnicom
$79.44 /

-0.22 (-0.28%)

12/15/20 Citi
Omnicom price target raised to $75 from $60 at Citi
11/02/20 Evercore ISI
Omnicom upgraded to In Line from Underperform at Evercore ISI
10/30/20 Huber Research
Omnicom upgraded to Overweight from Underweight at Huber Research
10/28/20
Fly Intel: Top five analyst upgrades
TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

OMC Omnicom
$79.44 /

-0.22 (-0.28%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

KEY KeyCorp
$20.43 /

-0.24 (-1.16%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

FITB Fifth Third
$37.91 /

-0.29 (-0.76%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

TRV Travelers
$154.45 /

-1.5 (-0.96%)

PM Philip Morris
$91.63 /

-1.29 (-1.39%)

PG Procter & Gamble
$136.45 /

-0.72 (-0.52%)

LMT Lockheed Martin
$391.87 /

+0.03 (+0.01%)

JNJ Johnson & Johnson
$162.98 /

+0.83 (+0.51%)

ABT Abbott
$124.67 /

+0.3 (+0.24%)

Earnings
Notable companies reporting before tomorrow's open » 14:11
04/19/21
04/19
14:11
04/19/21
14:11
JNJ

Johnson & Johnson

$162.24 /

+0.09 (+0.06%)

, PG

Procter & Gamble

$136.73 /

-0.44 (-0.32%)

, ABT

Abbott

$125.24 /

+0.87 (+0.70%)

, PM

Philip Morris

$92.94 /

+0.02 (+0.02%)

, LMT

Lockheed Martin

$390.82 /

-1.02 (-0.26%)

, TRV

Travelers

$154.02 /

-1.93 (-1.24%)

, FITB

Fifth Third

$37.87 /

-0.33 (-0.86%)

, KEY

KeyCorp

$20.54 /

-0.13 (-0.63%)

, OMC

Omnicom

$79.43 /

-0.23 (-0.29%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $2.34... Procter & Gamble (PG), consensus $1.19... Abbott (ABT), consensus $1.27... Philip Morris (PM), consensus $1.40... Lockheed Martin (LMT), consensus $6.30... Travelers (TRV), consensus $2.37... Fifth Third Bancorp (FITB), consensus 69c... KeyCorp (KEY), consensus 48c... Omnicom (OMC), consensus $1.13.

ShowHide Related Items >><<
TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
ABT Abbott
$125.24 /

+0.87 (+0.70%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
PM Philip Morris
$92.94 /

+0.02 (+0.02%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
TRV Travelers
$154.02 /

-1.93 (-1.24%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

04/09/21 Jefferies
Fifth Third price target raised to $44 from $36 at Jefferies
04/07/21 Barclays
Fifth Third price target raised to $43 from $37 at Barclays
04/01/21 Wells Fargo
Fifth Third price target raised to $36 from $28 at Wells Fargo
04/01/21 Deutsche Bank
Fifth Third price target raised to $38 from $30 at Deutsche Bank
KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

04/19/21 Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
OMC Omnicom
$79.43 /

-0.23 (-0.29%)

12/15/20 Citi
Omnicom price target raised to $75 from $60 at Citi
11/02/20 Evercore ISI
Omnicom upgraded to In Line from Underperform at Evercore ISI
10/30/20 Huber Research
Omnicom upgraded to Overweight from Underweight at Huber Research
10/28/20
Fly Intel: Top five analyst upgrades
TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

Recommendations
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett » 09:50
04/19/21
04/19
09:50
04/19/21
09:50
KEY

KeyCorp

$20.68 /

+0.01 (+0.05%)

, CMA

Comerica

$70.16 /

+0.03 (+0.04%)

Don Bilson, who heads…

Don Bilson, who heads event-driven research at Gordon Haskett, said in a note to investors that it is "getting harder to ignore the consolidation wave that is now rolling through the regional banking space." In that context, he noted that "a couple of other banks we have our eye on will be reporting tomorrow," specifically KeyBank (KEY) and Comerica (CMA). While stating that he has "always thought" Comerica "would be a nice pickup" for KeyBank to turn the latter into a national bank, Bilson added that "to be clear, we don't assign a very high probability to this happening." However, "just to hedge our bets," Bilson noted that jet tracking data shows that a KeyBank jet flew to Dallas last Wednesday, adding that data going back 18 months "has never seen KEY in Dallas before." Comerica's corporate headquarters is located in Dallas, Texas.

ShowHide Related Items >><<
KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
03/30/21 Stephens
KeyCorp price target raised to $23 from $20 at Stephens
CMA Comerica
$70.16 /

+0.03 (+0.04%)

04/09/21 Jefferies
Comerica price target raised to $74 from $63 at Jefferies
04/07/21 Barclays
Comerica price target raised to $67 from $65 at Barclays
04/01/21 Wells Fargo
Comerica price target raised to $65 from $54 at Wells Fargo
03/30/21 Stephens
Comerica price target raised to $82 from $74 at Stephens
KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

KEY KeyCorp
$20.68 /

+0.01 (+0.05%)

CMA Comerica
$70.16 /

+0.03 (+0.04%)

Friday
Earnings
TD Bank comments on expected impact of Schwab's Q1 earnings » 06:41
04/16/21
04/16
06:41
04/16/21
06:41
TD

Toronto-Dominion

$65.92 /

-0.36 (-0.54%)

TD Bank Group announced…

TD Bank Group announced that it expects Charles Schwab's first quarter earnings to translate into approximately C$223M of reported equity in net income of an investment in Schwab for the Bank's fiscal 2021 second quarter. Excluding acquisition-related charges of approximately C$15M after-tax and amortization of acquired intangibles of approximately C$34M after-tax, adjusted equity in net income of an investment in Schwab will be approximately C$272M.

ShowHide Related Items >><<
TD Toronto-Dominion
$65.92 /

-0.36 (-0.54%)

TD Toronto-Dominion
$65.92 /

-0.36 (-0.54%)

03/01/21 Desjardins
Toronto-Dominion price target raised to C$83 from C$79 at Desjardins
02/26/21 Canaccord
Toronto-Dominion price target raised to C$83 from C$77.50 at Canaccord
02/26/21 BMO Capital
Toronto-Dominion price target raised to C$82 from C$75 at BMO Capital
02/26/21 RBC Capital
Toronto-Dominion price target raised to C$82 from C$79 at RBC Capital
TD Toronto-Dominion
$65.92 /

-0.36 (-0.54%)

TD Toronto-Dominion
$65.92 /

-0.36 (-0.54%)

Thursday
Hot Stocks
U.S. Bancorp sees Q2 net charge-off ratio likely to remain low » 11:16
04/15/21
04/15
11:16
04/15/21
11:16
USB

U.S. Bancorp

$55.05 /

-2.51 (-4.36%)

Moving further into the…

Moving further into the year, U.S. Bancorp expects NCO ratio to normalize toward pre-pandemic levels.

ShowHide Related Items >><<
USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

04/12/21 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
04/09/21 Jefferies
U.S. Bancorp price target raised to $66 from $55 at Jefferies
04/08/21 JPMorgan
U.S. Bancorp upgraded to Overweight on spending recovery at JPMorgan
04/08/21 JPMorgan
U.S. Bancorp upgraded to Overweight from Neutral at JPMorgan
USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

USB U.S. Bancorp
$55.05 /

-2.51 (-4.36%)

Hot Stocks
U.S. Bancorp sees Q2 noninterest expense relatively stable vs. Q1  11:16
04/15/21
04/15
11:16
04/15/21
11:16
USB

U.S. Bancorp

$54.99 /

-2.57 (-4.46%)

 
ShowHide Related Items >><<
USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

04/12/21 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
04/09/21 Jefferies
U.S. Bancorp price target raised to $66 from $55 at Jefferies
04/08/21 JPMorgan
U.S. Bancorp upgraded to Overweight on spending recovery at JPMorgan
04/08/21 JPMorgan
U.S. Bancorp upgraded to Overweight from Neutral at JPMorgan
USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

USB U.S. Bancorp
$54.99 /

-2.57 (-4.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.